Eli Lilly bets $2.75B on AI-developed drugs- Daily Shorts | USA

Pharmaceutical giant Eli Lilly has signed a $2.75 billion deal with Hong Kong-based Insilico Medicine to bring artificial intelligence-developed drugs...

Pharmaceutical giant Eli Lilly has signed a $2.75 billion deal with Hong Kong-based Insilico Medicine to bring artificial intelligence-developed drugs...